Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2019

01-02-2019 | Thrombocytopenia

Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia

Authors: Pannaga Malalur, Charles Greenberg, Ming Y. Lim

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2019

Login to get access

Abstract

A high frequency of PF4-ELISA testing in patients suspected to have heparin-induced thrombocytopenia (HIT) despite low 4T scores has been observed in multiple medical centers. Education of clinicians has been suggested to reduce inappropriate testing. We determined trends of PF4-ELISA testing in our institution after the introduction of a HIT education program for clinicians. A HIT Program was developed that included ongoing education, individual feedback, and continuous clinical audit of PF4-ELISA utilization. To assess the impact of education on PF4-ELISA testing trends, we conducted a prospective cohort review of all adult patients who had a PF4-ELISA ordered over a 3 month period (the last quarter of the academic year). 72 PF4-ELISA tests were ordered during the study period. Prospectively calculated 4T scores by investigators revealed 60 low-risk (83.3%), 9 intermediate-risk (12.5%), and 3 high-risk (4.16%). We observed divergent 4T scores with the ordering clinician calculating a higher 4T score compared to the Hematology Quality Improvement (QI) team. The majority of PF4-ELISA testing was ordered by the intensive care units (ICUs) (n = 32, 44.44%). Our study revealed that the frequency of calculation of 4T scores remains poor with the majority inappropriately performed in the ICU setting, with ordering clinicians calculating higher 4T scores than the Hematology QI team. This suggests that clinician education alone is insufficient. Introducing mandatory 4T score calculation prior to PF4-ELISA testing may not be helpful as ordering clinicians can bypass the restriction through inaccurate 4T score calculation.
Literature
2.
go back to reference Girolami B, Prandoni P, Stefani PM, Tanduo C, Sabbion P, Eichler P, Ramon R, Baggio G, Fabris F, Girolami A (2003) The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101(8):2955–2959. https://doi.org/10.1182/blood-2002-07-2201 CrossRefPubMed Girolami B, Prandoni P, Stefani PM, Tanduo C, Sabbion P, Eichler P, Ramon R, Baggio G, Fabris F, Girolami A (2003) The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101(8):2955–2959. https://​doi.​org/​10.​1182/​blood-2002-07-2201 CrossRefPubMed
5.
go back to reference Greinacher A, Eichler P, Lubenow N, Kwasny H, Luz M (2000) Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 96(3):846–851PubMed Greinacher A, Eichler P, Lubenow N, Kwasny H, Luz M (2000) Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 96(3):846–851PubMed
11.
14.
go back to reference Landau DA, Kholodnaya N, CuestaFernandez A, PerezPerez A (2015) The appropriateness of heparin antibody testing. A single institution retrospective analysis. Blood 126(23):3277 Landau DA, Kholodnaya N, CuestaFernandez A, PerezPerez A (2015) The appropriateness of heparin antibody testing. A single institution retrospective analysis. Blood 126(23):3277
15.
go back to reference Mariampillai AI, Dela Cruz JP, Staszewski H, D’Abreo N (2016) Heparin-induced thrombocytopenia antibody testing and its cost effectiveness: taking a financial hit. Blood 128(22):2343 Mariampillai AI, Dela Cruz JP, Staszewski H, D’Abreo N (2016) Heparin-induced thrombocytopenia antibody testing and its cost effectiveness: taking a financial hit. Blood 128(22):2343
16.
go back to reference Schaffner M, Perepu U (2017) Striving to hit the bullseye when diagnosing heparin-induced thrombocytopenia. Blood 130(Suppl 1):4639 Schaffner M, Perepu U (2017) Striving to hit the bullseye when diagnosing heparin-induced thrombocytopenia. Blood 130(Suppl 1):4639
17.
go back to reference Smith M, Dowell JE, Frenkel EP, Sarode R, Shen YP (2011) Initial management of suspected heparin-induced thrombocytopenia: opportunities for education. Blood 118(21):4686 Smith M, Dowell JE, Frenkel EP, Sarode R, Shen YP (2011) Initial management of suspected heparin-induced thrombocytopenia: opportunities for education. Blood 118(21):4686
18.
go back to reference Nandi PL, Chan JN, Chan CP, Chan P, Chan LP (2000) Undergraduate medical education: comparison of problem-based learning and conventional teaching. Hong Kong Med J 6(3):301–306PubMed Nandi PL, Chan JN, Chan CP, Chan P, Chan LP (2000) Undergraduate medical education: comparison of problem-based learning and conventional teaching. Hong Kong Med J 6(3):301–306PubMed
21.
go back to reference McClellan WM, Millman L, Presley R, Couzins J, Flanders WD (2003) Improved diabetes care by primary care physicians: results of a group-randomized evaluation of the Medicare Health Care Quality Improvement Program (HCQIP). J Clin Epidemiol 56(12):1210–1217CrossRefPubMed McClellan WM, Millman L, Presley R, Couzins J, Flanders WD (2003) Improved diabetes care by primary care physicians: results of a group-randomized evaluation of the Medicare Health Care Quality Improvement Program (HCQIP). J Clin Epidemiol 56(12):1210–1217CrossRefPubMed
22.
go back to reference Newman DHBJ, Ackerman B, Hsieh W, Yang H, Kyrillou E, Krashaur M, Tse AB, Sharp VE (2008) Can physician education improve patient use of a free rapid HIV testing program? Ann Emerg Med 52(4):S121CrossRef Newman DHBJ, Ackerman B, Hsieh W, Yang H, Kyrillou E, Krashaur M, Tse AB, Sharp VE (2008) Can physician education improve patient use of a free rapid HIV testing program? Ann Emerg Med 52(4):S121CrossRef
23.
go back to reference van der Weijden T, Grol RP, Knottnerus JA (1999) Feasibility of a national cholesterol guideline in daily practice. A randomized controlled trial in 20 general practices. Int J Qual Health Care 11(2):131–137CrossRefPubMed van der Weijden T, Grol RP, Knottnerus JA (1999) Feasibility of a national cholesterol guideline in daily practice. A randomized controlled trial in 20 general practices. Int J Qual Health Care 11(2):131–137CrossRefPubMed
26.
go back to reference Pierce W, Mazur J, Greenberg C, Mueller J, Foster J, Lazarchick J (2013) Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit. Ann Clin Lab Sci 43(4):429–435PubMed Pierce W, Mazur J, Greenberg C, Mueller J, Foster J, Lazarchick J (2013) Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit. Ann Clin Lab Sci 43(4):429–435PubMed
Metadata
Title
Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia
Authors
Pannaga Malalur
Charles Greenberg
Ming Y. Lim
Publication date
01-02-2019
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2019
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-01803-8

Other articles of this Issue 2/2019

Journal of Thrombosis and Thrombolysis 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.